Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.

Academics and policymakers convened at Presidency University to debate gene-edited rice in India. Discussions explored its ...

Radboudumc is the first hospital in the world to use a new genetic test on a large scale in clinical practice. This test provides more people with a diagnosis for rare conditions and is faster and ...

The unsung heroes of the lab and lecture hall have laid the groundwork for some of the most transformative technologies of ...

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...

Steven Salzberg, Mihaela Pertea, and Winston Timp were named to Clarivate's 2025 Highly Cited Researchers list for pioneering ...

What does it take to shape industries and inspire change in 2025? The Top 10 Influential Entrepreneurs in 2025 showcas ...

Elevidys now carries a black box warning for acute liver injury and failure, limiting its use to ambulatory patients aged four and older. The FDA's actions follow fatal liver failure reports in ...

The identification of 20 causal plasma proteins for prostate cancer represents a critical step toward addressing the need for improved diagnostic specificity and reveals promising new targets for ...

A habitat-building coralline algae that provides a vital nursing ground for marine species and an important blue carbon ...

AAV-SLB101 is a rationally designed capsid developed for enhanced skeletal muscle, cardiac tropism, and reduced biodistribution to the liver.

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...